Page last updated: 2024-08-17

medroxyprogesterone acetate and Torsade de Pointes

medroxyprogesterone acetate has been researched along with Torsade de Pointes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ackerman, MJ; Brost, BC; Giudicessi, JR; Traynor, KD1
Choi, BR; Koren, G; Odening, KE1
Skinner, JR; Vandenberg, JI1

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Torsade de Pointes

ArticleYear
Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome.
    Heart rhythm, 2012, Volume: 9, Issue:7

    Topics: Adult; Contraceptive Agents, Female; Defibrillators, Implantable; Delayed-Action Preparations; Female; Heart Conduction System; Humans; Hypodermoclysis; Injections, Intramuscular; Long QT Syndrome; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Progesterone; Prosthesis Failure; Tachycardia, Ventricular; Torsades de Pointes

2012
Sex hormones and cardiac arrest in long QT syndrome: does progesterone represent a potential new antiarrhythmic therapy?
    Heart rhythm, 2012, Volume: 9, Issue:7

    Topics: Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Pregnancy; Torsades de Pointes

2012
Is medroxyprogesterone safe in women with long QT syndrome?
    Heart rhythm, 2012, Volume: 9, Issue:7

    Topics: Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Pregnancy; Torsades de Pointes

2012